Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_assertion type Assertion NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_head.
- NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_assertion description "[Thus, P1465-hydroxylated Rpb1 and PHD1 represent attractive drug targets for new RCC treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_provenance.
- NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_assertion evidence source_evidence_literature NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_provenance.
- NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_assertion SIO_000772 20978146 NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_provenance.
- NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_assertion wasDerivedFrom befree-2016 NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_provenance.
- NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_assertion wasGeneratedBy ECO_0000203 NP848206.RAvZSmB-c1nzl3NBUR8rX19ePSEuXKxMDg1B6QSYV26y4130_provenance.